EDIT
Editas Medicine Inc
2.70$
-0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 1,156.9% | 941.3% | 605.8% | 283.9% | 472.0% | 174.1% | 19.8% | 32.1% | 7.8% | 616.6% | 13.0% | |
| – | -1,056.9% | -841.3% | -505.8% | -183.9% | -372.0% | 100.0% | 100.0% | 100.0% | 92.2% | -516.6% | 100.0% | |
| – | 1,156.9% | 941.3% | 605.8% | 283.9% | 472.0% | 174.1% | 557.9% | 887.6% | 227.4% | 616.6% | 222.0% | |
| – | 1,110.8% | 764.3% | 367.9% | 172.2% | 314.4% | 74.5% | 298.2% | 358.7% | 89.2% | 222.8% | 123.2% | |
| – | 2,267.7% | 1,705.6% | 973.6% | 456.1% | 314.4% | 248.6% | 856.1% | 1,246.3% | 308.8% | 260.6% | 345.2% | |
| – | -2,167.7% | -1,605.6% | -873.6% | -356.1% | -686.4% | -148.6% | -756.1% | -1,146.3% | -216.6% | -777.2% | -245.2% | |
| – | 8.8% | 1.0% | 7.1% | 10.8% | 35.6% | 2.9% | 22.3% | 21.4% | – | 6.8% | 15.2% | |
| – | -4,475.1% | -1,605.5% | -876.5% | -344.3% | -651.4% | -127.8% | -753.6% | -1,118.3% | -196.1% | -733.7% | -395.0% | |
| – | -2,318.8% | -21.8% | -8.1% | -9.8% | -50.1% | -7.2% | -29.0% | -81.6% | 7.5% | – | – | |
| – | -4,475.1% | -1,605.5% | -876.5% | -344.3% | -651.4% | -120.6% | -724.7% | -1,036.7% | -196.1% | -733.7% | -395.0% | |
| – | -4,437.4% | -1,587.1% | -849.8% | -345.9% | -672.6% | -144.3% | -736.3% | -1,114.1% | -188.4% | -721.4% | -366.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.